These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 289319)
41. Corticosteroid therapy in avian muscular dystrophy: evaluation by magnetic resonance relaxation times. Misra LK; Entrikin RK Exp Neurol; 1988 Nov; 102(2):217-20. PubMed ID: 3181360 [TBL] [Abstract][Full Text] [Related]
42. Fatigability of normal and dystrophic chicken muscle in vivo. Hoekman TB Exp Neurol; 1977 Mar; 54(3):565-78. PubMed ID: 191271 [No Abstract] [Full Text] [Related]
43. Isometric contractile properties of the posterior latissimus dorsi muscle in normal and genetically dystrophic chickens. Hoekman TB Exp Neurol; 1976 Dec; 53(3):729-43. PubMed ID: 1001396 [No Abstract] [Full Text] [Related]
44. Baclofen, procainamide, verapamil, and prenylamine in hereditary muscular dystrophy of the chicken. Entrikin RK; Patterson GT; Wilson BW Exp Neurol; 1981 Oct; 74(1):86-92. PubMed ID: 7286127 [No Abstract] [Full Text] [Related]
45. Nightmares treated with cyproheptadine. Gupta S; Austin R; Cali LA; Bhatara V J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):570-2. PubMed ID: 9628074 [No Abstract] [Full Text] [Related]
46. Development and maintenance of tetrodotoxin-sensitive action potential in cultured skeletal muscle cells from dystrophic and normal chickens. Yamazaki S; Kano M Exp Neurol; 1981 Nov; 74(2):408-18. PubMed ID: 7297626 [No Abstract] [Full Text] [Related]
47. Cannabis-induced catalepsy in mice: role of putative neurotransmitters. Ghosh P; Bose R; Bhattacharya SK Indian J Med Res; 1980 Oct; 72():605-9. PubMed ID: 7194856 [No Abstract] [Full Text] [Related]
48. Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice. Komatsu K; Inazuki K; Hosoya J; Satoh S Exp Neurol; 1986 Jan; 91(1):23-9. PubMed ID: 3940877 [TBL] [Abstract][Full Text] [Related]
51. Cyproheptadine and the treatment of an unconscious patient with the serotonin syndrome. Baigel GD Eur J Anaesthesiol; 2003 Jul; 20(7):586-8. PubMed ID: 12884999 [No Abstract] [Full Text] [Related]
52. Penicillamine in the therapy of hereditary muscular dystrophy in chickens. Milhorat JH; Milhorat AT Ann N Y Acad Sci; 1979; 317():370-3. PubMed ID: 289318 [TBL] [Abstract][Full Text] [Related]
53. Cyproheptadine in treatment of autism. Gudarzi SS; Yasamy M; Akhondzadeh S Eur Psychiatry; 2002 Jul; 17(4):230-1. PubMed ID: 12231270 [No Abstract] [Full Text] [Related]
54. Muscular dystrophy in the chicken. Feit H Arch Neurol; 1989 May; 46(5):484. PubMed ID: 2712743 [No Abstract] [Full Text] [Related]
55. Myopathy of hamster dystrophy: physiologic aspects. Ward MR Ann N Y Acad Sci; 1979; 317():18-29. PubMed ID: 289311 [No Abstract] [Full Text] [Related]
56. Glucagon treatment of muscular dystrophic mice: a lack of effect. Yen TT; Allan JA Experientia; 1974 Aug; 30(8):908. PubMed ID: 4413580 [No Abstract] [Full Text] [Related]
57. Tolerance of normal and dystrophic hamsters to d-tubocurarine. Bokdawala F; Jasmin G Rev Can Biol; 1969 Dec; 28(4):267-9. PubMed ID: 5369452 [No Abstract] [Full Text] [Related]
58. Glucagon treatment for muscular dystrophy in the mouse. Pope RS Am J Physiol; 1973 Sep; 225(3):518-20. PubMed ID: 4726484 [No Abstract] [Full Text] [Related]
59. Characterisation of headshaking syndrome--31 cases. Madigan JE; Bell SA Equine Vet J Suppl; 1998 Nov; (27):28-9. PubMed ID: 10485000 [TBL] [Abstract][Full Text] [Related]
60. Fibre types in chicken skeletal muscles and their changes in muscular dystrophy. Barnard EA; Lyles JM; Pizzey JA J Physiol; 1982 Oct; 331():333-54. PubMed ID: 7153905 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]